Having raised over $8 billion to directly assist millions of patients with life-threatening, chronic, and rare conditions, Alan is an accomplished strategic development officer and patient advocate with a track record of expertise in access-to-care initiatives and successfully expanding mission impact for nonprofit organizations. As Chief Growth and Strategy Officer at Patient Advocate Foundation, the first comprehensive nonprofit dedicated to helping patients navigate, access, and afford care, he develops and scales support for mission programs and initiatives that expand access to affordable, equitable healthcare and improve health outcomes.
With more than 30 years leading business development and management strategies in the healthcare nonprofit and pharmaceutical sectors, Alan brings a deep commitment to advancing healthcare access, equity, and affordability. Prior to the 2026 strategic merger between Patient Advocate Foundation and the PAN Foundation, Alan served as Chief Growth and Strategy Officer at the PAN Foundation, where he worked to accelerate access to affordable, equitable healthcare through its advocacy, education, and financial assistance programs.
Previously, Alan served as Chief Development Officer at HealthWell Foundation. His career also includes leadership roles in the pharmaceutical sector managing large-scale transactions, revenue growth, and strategic product development. Throughout his career, Alan has spent more than 30 years in senior-level business/corporate development and management positions at pre-revenue, small, and large organizations within the pharmaceutical and biotechnology industries. In addition, he has been responsible for the management of revenue growth and portfolio investments, profit management, and supervision of strategic product development programs in these prior roles.
Alan received his MBA from Johns Hopkins University and a BA from the University of Maryland.